Carlie De Vries PhD

Dr. Carlie J.M. de Vries is Professor of Medical Cell Biochemistry at the Faculty of Medicine of the University of Amsterdam (AMC-UvA), heading the Vascular Cell Biology group. Carlie de Vries uses her research to gain detailed insight into the molecular processes involved in the initiation and progression of atherosclerosis. Atherosclerosis is a condition affecting the arterial vessel wall that can ultimately lead to obstruction of normal blood flow resulting in a heart attack or stroke. Through her molecular biological research, de Vries is able to identify genes that have a key regulatory function in atherosclerosis. The resulting insights are used towards early patient diagnosis and to develop innovative treatment strategies. De Vries works in close collaboration with cardiologists at the AMC, thus ensuring maximum integration with clinical practice and the translation of new fundamental knowledge into practical applications. Recently, de Vries received a research subsidy totaling five million euros from Biomedical Materials to conduct basic scientific vascular research and to collaborate with three small companies and TU Delft on the development of a safer sten